Melissa Dowd
Community Health · Athens, GANPI 1780993121
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,099 of the $8,011 with a category attached, or 88.6%. It is spread thinly across 60 manufacturers, the largest accounting for just 9.0% — the pattern of someone who eats at a lot of different presentations.
Across 371 payments — averaging $21.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$719
- Pharmacyclics LLC, An Abbvie Company$517
- Seagen Inc.$500
- Merck$445
- Novartis$374
- US Oncology Corporate, Inc.$360
- plus $5K from 54 others
What the payments were for
- Consulting fees$3604%
- Food & beverage$7,09989%
- Education$5527%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few community health providers in Georgiato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Varenicline Tartrate | 12 | $2,732 |
| Gabapentin | 158 | $1,376 |
| Duloxetine Hcl | 127 | $1,349 |
| Pregabalin | 59 | $602 |
| Tramadol Hcl | 47 | $479 |
| Buspirone Hcl | 72 | $453 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 45 | $375 |
| Mirtazapine | 36 | $362 |
| Clonazepam | 37 | $359 |
| Ondansetron OdtOndansetron | 12 | $244 |
| Cyclobenzaprine Hcl | 14 | $228 |
| Citalopram HbrCitalopram Hydrobromide | 67 | $178 |
| Alprazolam | 46 | $164 |
| Prochlorperazine Maleate | 17 | $150 |
| Hydroxyzine Hcl | 27 | $148 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCOlanzapine | $267 | $11512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few community health providers in Georgiaon file to place this against a meaningful peer group, so we don't.
Other community health in Athens
- April WashingtonMoultrie$2K
- Emma WalkerBainbridge$1K
- Eleanor QuincySavannah$973
- Kimberly ClarkbrakeMidville$288
- Lauren TiernanAugusta$188
- Nissa HaugenDalton$167
- Marguerite LawrenColumbus$103
- Abigail EdwardsAtlanta$101
- Joshua KiesSavannah$94
- Rene GuildBlue Ridge$90
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.